Breanne Bishop
Family · Mobile, ALNPI 1699307942
Payments from drug & device makers
Across 126 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$618
- Johnson & Johnson$302
- Lilly USA, LLC$276
- Sanofi$133
- Pfizer$124
- QOL Medical, LLC$95
- plus $753 from 18 others
What the payments were for
- Food & beverage$2,21796%
- Education$844%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $618 |
| Johnson & Johnson | 14 | $302 |
| Lilly USA, LLC | 16 | $276 |
| Sanofi | 5 | $133 |
| Pfizer | 7 | $124 |
| QOL Medical, LLC | 4 | $95 |
| Novo Nordisk | 6 | $84 |
| Ardelyx, Inc. | 5 | $81 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| GSK | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 5 | $56 |
| Bayer | 3 | $54 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| Corcept Therapeutics | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Exact Sciences | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| SK Life Science, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$2,301 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 42 | $506 |
| Methylprednisolone | 45 | $374 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $359 |
| Omeprazole | 25 | $351 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $315 |
| Doxycycline Hyclate | 41 | $270 |
| Cefdinir | 19 | $246 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $231 |
| Mupirocin | 15 | $133 |
| Azithromycin | 21 | $123 |
| Atorvastatin Calcium | 11 | $112 |
| Cephalexin | 11 | $98 |
| Amlodipine Besylate | 13 | $62 |
| Tizanidine Hcl | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other family in Mobile
- Christopher LovellMobile$64K
- Sanjyot BhadkamkarMobile$16K
- Freda SmithMobile$14K
- Alexandria HellmichMobile$13K
- Kara BoutwellMobile$12K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.